Progress of research on Proto-oncogene c-myc, c-myb in platelet diseases.
- Author:
Ying ZHANG
1
;
Rui CHEN
;
Li ZHAO
Author Information
1. Central Laboratory, Lanzhou University First Hospital, Lanzhou 730000, Gansu Province, China.
- Publication Type:Journal Article
- MeSH:
Blood Platelet Disorders;
genetics;
metabolism;
Humans;
Proto-Oncogene Proteins c-myb;
genetics;
metabolism;
Proto-Oncogene Proteins c-myc;
genetics;
metabolism
- From:
Journal of Experimental Hematology
2011;19(1):274-278
- CountryChina
- Language:Chinese
-
Abstract:
The Proto-oncogene c-myc and c-myb has been shown to be crucial in the development of the hematopoietic system. The changes in the expression of c-myc are concerned the cell proliferation and differentiation, the expression products of which play an important regulatory role in cell growth, differentiation or malignant transformation. The c-myb involves in transcription and affects cell proliferation, differentiation, apoptosis. More recently, the researches on proto-oncogene c-myc, c-myb in hematopoietic regulation have gradually increased along with development of molecular biology, molecular immunology and cell biology. Scientists point out that the directive differentiation of erythroid and megakaryocytic progenitors, and platelet abnormalities all relate to the level of their expressions. The most common thrombocytopathy includes thrombocytopenia, thrombocytosis and so on. The etiology and the mechanism of these diseases are unknown. This article reviews the structure, function and the expression of c-myc and c-myb in platelet diseases and their significance.
